학술논문

A Randomized Phase II Study of Nivolumab Monotherapy or Nivolumab Combined with Ipilimumab in Patients with Advanced Gastrointestinal Stromal Tumors
Document Type
Article
Source
In: Clinical Cancer Research. (Clinical Cancer Research, 1 January 2022, 28(1):84-94)
Subject
Language
English
ISSN
15573265
10780432